Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. (Q44372506)
Jump to navigation
Jump to search
scientific article published in February 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. |
scientific article published in February 2003 |
Statements
Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy (English)
Lawrence Yannuzzi
Jason S Slakter
Janice A Jerdan
Anecortave Acetate Clinical Study Group
Patricia Zilliox
Donald J D'Amico
Morton F Goldberg
Henry Hudson
Scott Krueger
Susan Luna
Stella M Robertson
E Kenneth Sullivan
1 February 2003